Comparing immediate and delayed surgery for eye membrane issues
Official title: Randomized Trial Comparing Immediate Versus Deferred Surgery for Symptomatic Epiretinal Membranes
Run by Jaeb Center for Health Research · NCT05145491 · Data updated 2026-11-12
This study is testing whether having eye surgery right away or waiting a bit longer helps people with vision problems from eye membrane issues see better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Jaeb Center for Health Research Academic / other |
| Locations | 49 sites (Scottsdale, Arizona and 48 other locations) |
| Status | Recruiting |
| Started | February 22, 2022 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT05145491 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 45 and older with good vision (20/40 or better) who have symptomatic ERM believed to be the primary cause of their vision issues.
✕Probably not a fit
Patients with a history of retinal vascular disease or those requiring immediate surgery due to severe vision loss may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the outcomes of immediate versus deferred vitrectomy surgery for patients with symptomatic epiretinal membranes (ERM). It aims to determine whether delaying surgery affects visual acuity and to identify predictors of outcomes based on the timing of the procedure. The study will also explore the use of objective measures of visual distortion in evaluating ERMs. Participants will be monitored to assess the impact of their chosen treatment approach on their vision over time.
Why it matters
Potential benefit: If successful, this study could help determine the optimal timing for surgery, potentially improving visual outcomes for patients with ERM.
How similar studies have gone: While the approach of comparing immediate and deferred surgery is common, the specific use of objective measures of visual distortion in this context is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Key Inclusion Criteria:
* Age ≥ 45 years
* E-ETDRS visual acuity 20/40 or better (≥69 letters)
o ERM must be thought to be the primary cause of vision loss
* ERM meeting the following criteria, according to the investigator
* ERM is not secondary to another condition
* Symptoms of visual loss and/or distortion (in the opinion of the investigator, the ERM is contributing to the participant's symptoms); either new or worsening in the past 24 months
* Epiretinal membrane involving or altering the central 3 mm of the macula on OCT
* Distortion within the central subfield due to ERM on OCT
* Immediate vitrectomy not required (investigator and participant are willing to wait at least 4 weeks to see if vision remains stable without having to proceed to vitrectomy)
* No known medical problems that will be a contraindication to surgery
Key Exclusion Criteria:
* History of retinal vascular disease
* History of vitreous hemorrhage if vitreous hemorrhage is thought to have caused the ERM
o History of vitreous hemorrhage is permitted provided the vitreous hemorrhage did not cause the ERM in the investigator's opinion
* History of inflammatory disease unless mild and completely resolved at least one year prior to randomization
* History of diabetic macular edema (DME), retinal vein occlusion (RVO), or uveitis (except mild uveitis that resolved \>1 year prior to randomization)
* Prior intraocular surgery (except uncomplicated cataract extraction)
* Cataract extraction within prior 3 months
* Laser or cryosurgical retinopexy within one month of randomization
* Pneumatic retinopexy within one year of randomization
* Current untreated retinal tear or detachment
o A previously treated retinal tear with up to one disc diameter radius of subretinal fluid is permitted
* Macular hole
* Degenerative lamellar macular hole
o ERM foveoschisis ("tractional" lamellar hole) is permitted
* Vitreomacular traction within 1,500 microns of foveal center
* Central serous chorioretinopathy
* Nonproliferative diabetic retinopathy or worse (DR severity \>20)
Where it's running
-
Mayo Clinic Arizona
Scottsdale, Arizona, United States Recruiting -
Kent W. Small, MD, AMC
Glendale, California, United States Recruiting -
Salehi Retina Institute Inc.
Huntington Beach, California, United States Recruiting -
Loma Linda University
Loma Linda, California, United States Recruiting -
Retina Vitreous Associates, Northern California Retina Vitreous Assoc Medical Group, Inc.
Mountain View, California, United States Recruiting -
East Bay Retina Consultants, Inc.
Oakland, California, United States Recruiting
Show 43 more locations
-
Regents of the University of California, Davis, DBA University of California, Davis
Sacramento, California, United States Recruiting -
Macula Retina Vitreous Institute
Torrance, California, United States Recruiting -
Florida Retina Institute, James A. Staman, MD, PA- Jacksonville
Jacksonville, Florida, United States Recruiting -
Sarasota Retina Institute
Sarasota, Florida, United States Recruiting -
SEASHORE RETINA LLC DBA Retina Specialists of Tampa
Wesley Chapel, Florida, United States Recruiting -
Southeast Retina Center, P.C.
Augusta, Georgia, United States Recruiting -
Thomas Eye Group
Sandy Springs, Georgia, United States Recruiting -
Northwestern University
Chicago, Illinois, United States Recruiting -
Rush University Medical Center
Chicago, Illinois, United States Recruiting -
UIC - Department of Ophthalmology and Visual Sciences
Chicago, Illinois, United States Recruiting -
Illinois Retina Associates SC - Oak Park Site
Oak Park, Illinois, United States Recruiting -
Raj K. Maturi, M.D., P.C.
Indianapolis, Indiana, United States Recruiting -
Mid-America Retina Consultants, P.A.
Overland Park, Kansas, United States Recruiting -
University of Kansas Medical Center Research Institute, Inc.
Prairie Village, Kansas, United States Recruiting -
Joseph E. Humble and Raymond Haik PTRS DBA Eye Assoc of Northeast Louisiana
West Monroe, Louisiana, United States Recruiting -
Elman Retina Group, P.A.
Baltimore, Maryland, United States Recruiting -
Johns Hopkins University
Baltimore, Maryland, United States Recruiting -
Valley Eye Physicians and Surgeons
Ayer, Massachusetts, United States Recruiting -
Joslin Diabetes Center
Boston, Massachusetts, United States Recruiting -
Retina Associates of Michigan
Grand Blanc, Michigan, United States Recruiting -
The Curators of the University of Missouri
Columbia, Missouri, United States Recruiting -
Retina Research Institute, LLC
St Louis, Missouri, United States Recruiting -
Retina-Vitreous Surgeons of Central NY, PC
Liverpool, New York, United States Recruiting -
Retina Associates of Western NY, P.C.
Rochester, New York, United States Recruiting -
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States Recruiting -
Retina Vitreous Center
Edmond, Oklahoma, United States Recruiting -
Verum Research LLC
Eugene, Oregon, United States Recruiting -
Cascade Medical Research Institute, LLC
Springfield, Oregon, United States Recruiting -
Retina-Vitreous Consultants, Inc.
Monroeville, Pennsylvania, United States Recruiting -
The Trustees of the University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting -
Pittsburg Clinical Trial Consortium
Sewickley, Pennsylvania, United States Recruiting -
Hilton Head Retina Institute
Hilton Head Island, South Carolina, United States Recruiting -
Ophthalmology Ltd.
Sioux Falls, South Dakota, United States Recruiting -
Vanderbilt Eye Institute
Nashville, Tennessee, United States Recruiting -
Austin Research Center for Retina
Austin, Texas, United States Recruiting -
Retina Consultants of Texas
Bellaire, Texas, United States Recruiting -
Baylor College of Medicine, Baylor Eye Physicians and Surgeons
Houston, Texas, United States Recruiting -
Texas Retina Associates
Lubbock, Texas, United States Recruiting -
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States Recruiting -
Retinal Consultants of San Antonio
San Antonio, Texas, United States Recruiting -
The Retina Group of Washington
Reston, Virginia, United States Recruiting -
Spokane Eye Clinical Research, PLLC
Spokane, Washington, United States Recruiting -
South Tyneside and Sunderland NHS Trust
Sunderland, Tyne and Wear, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PathFinder 1.0 detects retinal abnormalities on macular OCT scans
This study tests PathFinder 1.0's ability to find retinal issues on macular OCT scans in adults.
-
Minimal vitrectomy for epiretinal membrane
This trial tests whether a minimal vitrectomy technique helps adults with idiopathic epiretinal membrane improve vision and slow cataract progression compared with conventional vitrectomy.
-
Implanting functional intraocular lenses in patients with epiretinal membrane
This study is testing whether a special type of eye lens can improve vision better than a standard lens for cataract patients with a specific eye condition.
-
Using advanced imaging technology during eye surgery
This study is testing a new imaging technology during eye surgery to see if it can help doctors perform better and improve outcomes for patients with retinal diseases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.